Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 32.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 3.00 (9.375%)
Open: 33.50
High: 33.50
Low: 33.50
Prev. Close: 33.50
AIEA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) AIREA Plc

17 May 2018 10:05

RNS Number : 4139O
Nplus1 Singer Capital Markets Ltd
17 May 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AIREA Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

AIREA Plc

(d) Date dealing undertaken:

16 May 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ord 5p

 

 

Sale

 

10000

 

59.49p

 

59.49p

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

17 May 2018

Contact name:

Damian Fernandez

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGMGMKLNFGRZG
Date   Source Headline
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director
18th Mar 20224:45 pmRNSDirector's Leave of Absence
15th Nov 20217:00 amRNSChange of Auditor
7th Sep 20213:40 pmRNSHolding(s) in Company
30th Jul 20217:00 amRNSInterim Report
24th Jun 202112:22 pmRNSHolding(s) in Company
19th May 20213:34 pmRNSAppointment of Director and Company Secretary
12th May 20213:59 pmRNSResult of AGM
29th Apr 20215:04 pmRNSHolding(s) in Company
29th Apr 20214:50 pmRNSHolding(s) in Company
21st Apr 202111:39 amRNSHolding(s) in Company
15th Mar 20211:58 pmRNSDirectorate Change
4th Mar 20217:30 amRNSFinal results for the year ended 31 December 2020
30th Jul 20207:00 amRNSInterim Report
14th May 20202:17 pmRNSResult of AGM
1st May 20205:07 pmRNSAnnual General Meeting update
26th Mar 202012:18 pmRNSCovid-19 trading update, dividend and AGM
5th Mar 20205:47 pmRNSTypo correction to Final Results
5th Mar 20207:00 amRNSFinal results for the year ended 31 December 2019
14th Nov 20191:52 pmRNSGrant of Options
5th Aug 201910:47 amRNSHolding(s) in Company
2nd Aug 20197:00 amRNSInterim report for the six months ended 30 June 19
9th May 20193:20 pmRNSResult of AGM
5th Apr 201911:42 amRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSPreliminary Results
4th Feb 20197:00 amRNSTrading Update
17th Aug 20187:00 amRNSHalf-year Report
25th Jul 201812:00 pmRNSDirectorate Change
2nd Jul 20183:21 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.